Vimentin as a potential molecular target in cancer therapy Or Vimentin , an overview and its potential as a molecular target for cancer therapy | Semantic Scholar
Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy | Nature Communications
Vimentin activation in early apoptotic cancer cells errands survival pathways during DNA damage inducer CPT treatment in colon carcinoma model | Cell Death & Disease
Vimentin (Mesenchymal Cell Marker) - Clone rVIM/6431 | 7431
Vimentin Regulates Invasiveness and Is a Poor Prognostic Marker in Non-small Cell Lung Cancer | Anticancer Research
Vimentin - Wikipedia
Fibroblast Marker (Vimentin, alpha smooth muscle Actin, Hsp47, S100A4) Antibody Panel - Human, Mouse (ab254015)
Vimentin and cytokeratin: Good alone, bad together - ScienceDirect
Vimentin's role in cell signaling | Download Scientific Diagram
2D-DIGE-Based Proteomic Profiling with Validations Identifies Vimentin as a Secretory Biomarker Useful for Early Detection and Poor Prognosis in Oral Cancers
Life | Free Full-Text | Biomarker Potential of Vimentin in Oral Cancers
Vimentin (Mesenchymal Cell Marker) - Clone VM1170 | 7431
Frontiers | Impact of Vimentin on Regulation of Cell Signaling and Matrix Remodeling
![Anti-Vimentin antibody [V9] - Cytoskeleton Marker KO Tested (ab8069) | Abcam](https://www.abcam.com/ps/products/8/ab8069/Images/ab8069-277299-anti-vimentin-antibody-v9-cytoskeleton-marker-immunofluorescence.jpg "Anti-Vimentin antibody [V9] - Cytoskeleton Marker KO Tested (ab8069) | Abcam")
Anti-Vimentin antibody [V9] - Cytoskeleton Marker KO Tested (ab8069) | Abcam
Fibroblast Marker (Vimentin, alpha smooth muscle Actin, Hsp47, S100A4) Antibody Panel - Human, Mouse (ab254015)
Fibroblast Marker (Vimentin, alpha smooth muscle Actin, Hsp47, S100A4) Antibody Panel - Human, Mouse (ab254015)
Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease - eBioMedicine
Frontiers | Expression of vimentin alters cell mechanics, cell-cell adhesion, and gene expression profiles suggesting the induction of a hybrid EMT in human mammary epithelial cells
![Anti-Vimentin antibody [RV202] - Cytoskeleton Marker KO Tested (ab8978) | Abcam](https://www.abcam.com/ps/products/8/ab8978/Images/ab8978-277295-anti-vimentin-antibody-rv202-immunofluorescence.jpg "Anti-Vimentin antibody [RV202] - Cytoskeleton Marker KO Tested (ab8978) | Abcam")
Anti-Vimentin antibody [RV202] - Cytoskeleton Marker KO Tested (ab8978) | Abcam
Vimentin| Type III intermediate filament | Cancer Metastasis | OriGene
Anti-Vimentin Monoclonal Antibody(Clone: VIM/1937R)
Epithelial cell migration requires the interaction between the vimentin and keratin intermediate filaments | Scientific Reports
Vimentin (Mesenchymal Cell Marker) Monoclonal Antibody (VM452) (7431-MSM1-P1ABX)
